Coinfections in intensive care units. Has anything changed with Covid-19 pandemia?
Enterococcus faecium
Enterococcus faecalis
Pandemic
Stenotrophomonas maltophilia
Acinetobacter baumannii
DOI:
10.23750/abm.v94i3.13429
Publication Date:
2023-06-14
AUTHORS (8)
ABSTRACT
Since December 2019, the Coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2), has spread from China, becoming a pandemic. Bacterial and fungal co-infections may lead to increase in COVID-19 severity with decrease patients survive. The aim of this work was evaluate bacterial admitted ICU comparison recovered pre-COVID-19 era order understand whether pandemic had changed incidence overinfections ICU. In fact, epidemiological data should guide choice empirical therapy.During pandemic, AOUC Policlinico Bari organized dedicated ICUs for patient SARS-CoV-2. Blood cultures, urine, tracheobronchial aspirate were included analysis.Specimens 1905 analysed work. Comparing clinical isolates prevalence material vs. non-COVID-19 statistically significant differences detected A. baumannii complex, Aspergillus fumigatus, Escherichia coli, Haemophilus influenzae Serratia marcescens isolated aspirates; C. albicans urine samples, Enterococcus faecalis faecium blood culture.Although organisms are consistent those frequently associated healthcare infection, our suggest particular baumannii, Stenotrophomonas maltophilia spp. tract, E. cultures.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....